Assessment of drug-drug interactions: concepts and approaches, Xenobiotica, vol.31, issue.1, pp.499-538, 2001. ,
DOI : 10.3109/03602539709037591
Prediction of Drug Metabolism and Interactions on the Basis of in vitro Investigations, Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, vol.26, issue.3, pp.167-175, 2005. ,
DOI : 10.1146/annurev.pharmtox.40.1.133
Inhibition and induction of human cytochrome P450 enzymes: current status, Archives of Toxicology, vol.9, issue.2, pp.667-715, 2008. ,
DOI : 10.1007/s00204-008-0332-8
Optimal pollution control strategies in the presence of interacting toxicants, Water Research, vol.22, issue.11, pp.1443-1447, 1988. ,
DOI : 10.1016/0043-1354(88)90102-9
Application and Impact of Population Pharmacokinetics in the Assessment of Antiretroviral Pharmacotherapy, Clinical Pharmacokinetics, vol.5, issue.5 ,
DOI : 10.2165/00003088-200544060-00003
Towards a mechanism-based analysis of pharmacodynamic drug?drug interactions in vivo, Pharmacology & Therapeutics, vol.106, issue.1, pp.1-18, 2005. ,
DOI : 10.1016/j.pharmthera.2004.10.014
Quantitative Drug Interactions Prediction System (Q-DIPS), Clinical Pharmacokinetics, vol.I, issue.9, pp.631-640, 2001. ,
DOI : 10.2165/00003088-200140090-00001
Qualitative Analysis of the Role of Metabolites in Inhibitory Drug???Drug Interactions: Literature Evaluation Based on the Metabolism and Transport Drug Interaction Database, Chemical Research in Toxicology, vol.22, issue.2, pp.294-298, 2009. ,
DOI : 10.1021/tx800491e
In silico prediction of cytochrome P450 inhibitors, Drug Development Research, vol.21, issue.5, pp.417-429, 2006. ,
DOI : 10.1002/ddr.20108
Predicting Drug Metabolism Induction In Silico, Current Topics in Medicinal Chemistry, vol.6, issue.15, pp.1627-1640, 2006. ,
DOI : 10.2174/156802606778108924
The Challenge of Predicting Drug Toxicity in silico, Basic & Clinical Pharmacology & Toxicology, vol.6, issue.3, pp.195-208, 2006. ,
DOI : 10.1021/jm021080f
A COMBINED APPROACH TO DRUG METABOLISM AND TOXICITY ASSESSMENT, Drug Metabolism and Disposition, vol.34, pp.495-503, 2006. ,
DOI : 10.1124/dmd.105.008458
Kinetic Modelling in Systems Biology, 2009. ,
Progress in Simulation Modelling for Pharmacokinetics, Current Topics in Medicinal Chemistry, vol.3, issue.11, pp.1257-1268, 2003. ,
DOI : 10.2174/1568026033451961
Application of Full Physiological Models for Pharmaceutical Drug Candidate Selection and Extrapolation of Pharmacokinetics to Man, Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, vol.42, issue.3, pp.193-196, 2005. ,
DOI : 10.1016/S0378-4274(02)00374-0
Characterizing Uncertainty and Variability in Physiologically Based Pharmacokinetic Models: State of the Science and Needs for Research and Implementation, Toxicological Sciences, vol.99, issue.2, pp.395-402, 2007. ,
DOI : 10.1093/toxsci/kfm100
URL : https://hal.archives-ouvertes.fr/ineris-00963075
Physiologically-based kinetic modelling (PBK modelling): meeting the 25 Physiologically based pharmacokinetic analyses of simple mixtures, Environmental Health Perspectives, vol.102, pp.151-155, 1994. ,
Physiologically based pharmacokinetic/pharmacodynamic modeling of chemical mixtures and possible applications in risk assessment, Toxicology, vol.105, issue.2-3, pp.275-282, 1995. ,
DOI : 10.1016/0300-483X(95)03222-2
Exploration of an interaction threshold for the joint toxicity of trichloroethylene and 1,1-dichloroethylene: utilization of a PBPK model, Archives of Toxicology, vol.37, issue.2, pp.527-539, 1996. ,
DOI : 10.1007/s002040050310
Physiologically Based Pharmacokinetic Modeling of Metabolic Interactions between n-Hexane and Toluene in Humans., Journal of Occupational Health, vol.40, issue.4, pp.293-301, 1998. ,
DOI : 10.1539/joh.40.293
Application of Physiologically Based Pharmacokinetic Modelling to Combination Toxicology, Food and Chemical Toxicology, vol.34, issue.11-12, pp.1067-1073, 1996. ,
DOI : 10.1016/S0278-6915(97)00076-8
Physiological modeling of toxicokinetic interactions: implications for mixture risk assessment, Environmental Health Perspectives, vol.106, issue.Suppl 6, pp.1377-84, 1998. ,
DOI : 10.1289/ehp.98106s61377
Physiological Modeling of the Toxicokinetic Interactions in a Quaternary Mixture of Aromatic Hydrocarbons, Toxicology and Applied Pharmacology, vol.161, issue.3, pp.249-257, 1999. ,
DOI : 10.1006/taap.1999.8803
A PBPK Modeling-Based Approach to Account for Interactions in the Health Risk Assessment of Chemical Mixtures, Toxicological Sciences, vol.63, issue.1, pp.125-131, 2001. ,
DOI : 10.1093/toxsci/63.1.125
Physiological Approaches to the Prediction of Drug-Drug Interactions in Study Populations, Current Drug Metabolism, vol.4, issue.5, pp.347-356, 2003. ,
DOI : 10.2174/1389200033489307
Evaluation of Methods for Predicting Drug-drug Interactions by Monte Carlo Simulation, Drug Metabolism and Pharmacokinetics, vol.18, issue.2, pp.121-127, 2003. ,
DOI : 10.2133/dmpk.18.121
???In silico??? simulations to assess the ???in vivo??? consequences of ???in vitro??? metabolic drug???drug interactions, Drug Discovery Today: Technologies, vol.1, issue.4, pp.441-448, 2004. ,
DOI : 10.1016/j.ddtec.2004.10.002
Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling, Archives of Toxicology, vol.75, issue.3, pp.134-144, 2001. ,
DOI : 10.1007/s002040100216
Comparison of Pharmacokinetic Interactions and Physiologically Based Pharmacokinetic Modeling of PCB 153 and PCB 126 in Nonpregnant Mice, Lactating Mice, and Suckling Pups, Toxicological Sciences, vol.65, issue.1, pp.26-34, 2002. ,
DOI : 10.1093/toxsci/65.1.26
Visualization-Based Analysis for a Mixed-Inhibition Binary PBPK Model: Determination of Inhibition Mechanism, Journal of Pharmacokinetics and Pharmacodynamics, vol.31, issue.3, pp.215-242, 2004. ,
DOI : 10.1023/B:JOPA.0000039565.11358.94
-Xylene and Ethylbenzene, Inhalation Toxicology, vol.144, issue.3, pp.265-273, 2007. ,
DOI : 10.1007/s002040050292
URL : https://hal.archives-ouvertes.fr/halshs-01407951
Comparison of different approaches to predict metabolic drug-drug interactions, Xenobiotica, vol.37, pp.1257-1294, 2007. ,
Drug???drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 1: comparison of uniresponse and multiresponse designs using PopDes, Journal of Pharmacokinetics and Pharmacodynamics, vol.28, issue.3, pp.635-659, 2008. ,
DOI : 10.1007/s10928-008-9104-6
URL : https://hal.archives-ouvertes.fr/inserm-00383725
A physiologically based pharmacokinetic model linking plasma protein binding interactions with drug disposition, Research in Veterinary Science, vol.86, issue.2, pp.293-301, 2009. ,
DOI : 10.1016/j.rvsc.2008.07.003
The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models, Bioinformatics, vol.19, issue.4, pp.524-531, 2003. ,
DOI : 10.1093/bioinformatics/btg015
A physiome standards-based model publication paradigm, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, vol.77, issue.1, pp.1823-1844, 2009. ,
DOI : 10.1161/01.CIR.99.18.2466
Modeling physiological of metabolic interactions]. Env Risque Sante in press ,
URL : https://hal.archives-ouvertes.fr/ineris-00970469
MCSim: a simulation program, Journal of Statistical Software, vol.2, issue.9, 1997. ,
GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models, Bioinformatics, vol.25, issue.11, pp.1453-1454, 2009. ,
DOI : 10.1093/bioinformatics/btp162
URL : https://hal.archives-ouvertes.fr/ineris-00961935
Precision and sensitivity of pharmacokinetic models for cancer risk assessment: Tetrachloroethylene in mice, rats, and humans, Toxicology and Applied Pharmacology, vol.102, issue.2, pp.300-315, 1990. ,
DOI : 10.1016/0041-008X(90)90029-T
A Generic Toxicokinetic Model for Persistent Lipophilic Compounds in Humans: An Application to TCDD, Toxicological Sciences, vol.31, issue.1, pp.83-94, 1996. ,
DOI : 10.1093/toxsci/31.1.83